|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 73.00 EUR | +0.41% |
|
+1.88% | -33.82% |
| Jul. 16 | MedTech facing a three-front squeeze | ![]() |
| Jul. 14 | Biomérieux Showcases Latest Diagnostic Solutions and Innovations At ADLM 2026 | CI |
Insider Transaction History
Latest insider transactions for bioMérieux
| Date | Insider | Type | Main position | Quantity | Price | Amount | % Market Cap. | |
|---|---|---|---|---|---|---|---|---|
| 5/6/26 | Buy | Chairman | 779,245 | 70.00 | 54.54M | 0.6584% | ||
| 5/6/26 | Buy | Chairman | 779,245 | 70.00 | 54.54M | 0.6584% | ||
| 5/4/26 | Buy | Chairman | 404,367 | 71.96 | 29.1M | 0.3416% | ||
| 5/4/26 | Buy | Chairman | 404,367 | 71.96 | 29.1M | 0.3416% | ||
| 9/12/25 | Sell | 461 | 114.54 | 52.8K | 0.0004% | |||
| 9/12/25 | Sell | Chief Technology Officer | 99 | 114.54 | 11.34K | 0.0001% | ||
| 9/12/25 | Sell | Chief Technology Officer | 199 | 114.54 | 22.79K | 0.0002% | ||
| 9/12/25 | Sell | 1,838 | 114.54 | 211K | 0.0016% | |||
| 9/12/25 | Sell | Chief Technology Officer | 795 | 114.54 | 91.06K | 0.0007% | ||
| 9/12/25 | Sell | Chief Technology Officer | 393 | 114.54 | 45.01K | 0.0003% | ||
| 9/11/25 | Free | 3,700 | - | - | 0.0031% | |||
| 9/11/25 | Free | Chief Technology Officer | 973 | - | - | 0.0008% | ||
| 9/11/25 | Free | 925 | - | - | 0.0008% | |||
| 9/11/25 | Free | Chief Technology Officer | 243 | - | - | 0.0002% | ||
| 9/11/25 | Free | Chief Technology Officer | 492 | - | - | 0.0004% | ||
| 9/11/25 | Free | Chief Technology Officer | 1,969 | - | - | 0.0017% | ||
| 9/10/25 | Free | Executive/Senior Manager | 3,800 | - | - | 0.0032% | ||
| 9/10/25 | Free | Public Communications Manager | 3,000 | - | - | 0.0025% | ||
| 9/10/25 | Free | Chief Executive Officer | 6,300 | - | - | 0.0053% | ||
| 9/10/25 | Free | Chief Financial Officer | 1,250 | - | - | 0.0011% | ||
| 9/10/25 | Free | Executive/Senior Manager | 950 | - | - | 0.0008% | ||
| 9/10/25 | Free | Chief Executive Officer | 1,575 | - | - | 0.0013% | ||
| 9/10/25 | Free | Chief Financial Officer | 5,000 | - | - | 0.0042% | ||
| 9/10/25 | Free | Public Communications Manager | 750 | - | - | 0.0006% | ||
| 7/26/25 | Buy | Executive/Senior Manager | 164 | 91.84 | 15.06K | 0.0001% | ||
| 7/10/25 | Buy | Chief Technology Officer | 100 | 104.48 | 10.45K | 0.0001% | ||
| 7/9/25 | Buy | Chief Financial Officer | 167 | 91.84 | 15.34K | 0.0001% | ||
| 7/9/25 | Buy | Chief Technology Officer | 167 | 91.84 | 15.34K | 0.0001% | ||
| 7/8/25 | Buy | Public Communications Manager | 113 | 91.84 | 10.38K | 0.0001% | ||
| 3/28/25 | Sell | Chief Financial Officer | 2,550 | 117.40 | 299K | 0.0022% | ||
| 3/28/25 | Others | Chairman | 687,104 | - | - | 0.5805% | ||
| 3/28/25 | Others | Chairman | 1,236,739 | - | - | 1.0449% | ||
| 3/28/25 | Others | Chairman | 1,236,739 | - | - | 1.0449% | ||
| 3/28/25 | Others | Chairman | 229,025 | - | - | 0.1935% | ||
| 3/28/25 | Others | Chairman | 687,194 | - | - | 0.5806% | ||
| 3/28/25 | Others | Chairman | 229,025 | - | - | 0.1935% | ||
| 3/13/25 | Sell | Chief Executive Officer | 5,741 | 117.30 | 673K | 0.0049% | ||
| 3/12/25 | Sell | Chief Executive Officer | 5,741 | 117.30 | 673K | 0.0049% | ||
| 1/8/25 | Don | Chairman | 778,699 | - | - | 0.6579% | ||
| 1/8/25 | Don | Chairman | 778,699 | - | - | 0.6579% | ||
| 1/8/25 | Don | Chairman | 778,699 | - | - | 0.6579% | ||
| 12/25/24 | Don | Chairman | 2,336,097 | 906.84 | 2.12B | 1.9737% | ||
| 9/11/24 | Free | Chief Executive Officer | 7,625 | - | - | 0.0064% | ||
| 9/11/24 | Free | Executive/Senior Manager | 4,500 | - | - | 0.0038% | ||
| 9/11/24 | Free | Chief Financial Officer | 4,375 | - | - | 0.0037% | ||
| 9/11/24 | Free | 4,375 | - | - | 0.0037% | |||
| 9/11/24 | Free | Public Communications Manager | 3,375 | - | - | 0.0029% | ||
| 9/11/24 | Sell | 1,637 | 109.93 | 180K | 0.0014% | |||
| 9/7/23 | Sell | Chief Technology Officer | 1,567 | 96.03 | 150K | 0.0013% | ||
| 9/7/23 | Fiscal year | Executive/Senior Manager | 3,750 | - | - | 0.0032% | ||
- Stock Market
- Stocks
- BIM Stock
- Company bioMérieux
- Insider transactions
Select your edition
All financial news and data tailored to specific country editions

















